A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (INTEGRATEIIa)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02773524 |
|
Recruitment Status :
Active, not recruiting
First Posted : May 16, 2016
Last Update Posted : January 13, 2022
|
Sponsor:
Australasian Gastro-Intestinal Trials Group
Collaborators:
Canadian Cancer Trials Group
Academic and Community Cancer Research United
National Health and Medical Research Council, Australia
Information provided by (Responsible Party):
Australasian Gastro-Intestinal Trials Group
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | January 2022 |
| Estimated Study Completion Date : | December 2022 |